Braden M. Leonard - 26 Oct 2022 Form 4 Insider Report for Gemini Therapeutics, Inc. /DE (IRON)

Role: 10%+ Owner
Signature: Braden Michael Leonard
Issuer symbol: IRON
Transactions as of: 26 Oct 2022
Net transactions value: -$47,025
Form type: 4
Filing time: 27 Oct 2022, 16:23:13 UTC
Previous filing: 26 Oct 2022
Next filing: 31 Oct 2022
SEC: View on sec.gov

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	IRON	Common Stock	Sale	$47,025	-22,500	-8.3%	$2.09^*	247,500	26 Oct 2022	Direct	F2
holding	IRON	Common Stock						5,000,000	26 Oct 2022	Holding of BML Investment Partners, L.P.	F1

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	Explanation of Responses: 1. BML Capital Management, LLC ("BML Capital") serves as the general partner of BML Investment Partners, L.P., a Delaware limited partnership (the "Fund"), which is the direct owner of the subject shares. Mr. Leonard is the managing member of BML Capital, and exercises investment and voting control over the subject shares. Accordingly, shares owned directly by the Fund may be regarded as being beneficially owned by Mr. Leonard. Notwithstanding, Mr. Leonard disclaims beneficial ownership of such shares, except to the extent of his pecuniary interest therein.
F2	The shares were sold in multiple transactions at $2.09.

Content

Explanation of Responses: 1. BML Capital Management, LLC ("BML Capital") serves as the general partner of BML Investment Partners, L.P., a Delaware limited partnership (the "Fund"), which is the direct owner of the subject shares. Mr. Leonard is the managing member of BML Capital, and exercises investment and voting control over the subject shares. Accordingly, shares owned directly by the Fund may be regarded as being beneficially owned by Mr. Leonard. Notwithstanding, Mr. Leonard disclaims beneficial ownership of such shares, except to the extent of his pecuniary interest therein.

The shares were sold in multiple transactions at $2.09.